Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes.
Armitage LH, Stimpson SE, Santostefano KE, Sui L, Ogundare S, Newby BN, Castro-Gutierrez R, Huber MK, Taylor JP, Sharma P, Radichev IA, Perry DJ, Fredette NC, Savinov AY, Wallet MA, Terada N, Brusko TM, Russ HA, Chen J, Egli D, Mathews CE.
Armitage LH, et al. Among authors: newby bn.
Front Endocrinol (Lausanne). 2021 Nov 9;12:737276. doi: 10.3389/fendo.2021.737276. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34858326
Free PMC article.